Effectiveness of a community pharmacist intervention in diabetes care: A randomized controlled trial

Journal of Clinical Pharmacy and Therapeutics

Volumn 36, Issue 5, 2011, Pages 602-613

  Mehuys, E ^a   Van Bortel, L ^b   De Bolle, L ^a   Van Tongelen, I ^a   Annemans, L ^a   Remon, J P ^a   Giri, M ^c  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

community pharmacy; pharmaceutical care; randomized controlled trial; type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ARTICLE; BELGIUM; CONTROLLED STUDY; DIABETIC PATIENT; EDUCATION PROGRAM; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PHARMACEUTICAL CARE; PHARMACIST; PHARMACY; RANDOMIZED CONTROLLED TRIAL; SELF CARE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BELGIUM; BLOOD GLUCOSE; COMMUNITY PHARMACY SERVICES; DIABETES MELLITUS, TYPE 2; DISEASE MANAGEMENT; DRUG PRESCRIPTIONS; FEMALE; HEALTH SERVICES RESEARCH; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; LIFE STYLE; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PHARMACIES; PHARMACISTS; SELF CARE; TIME FACTORS; TREATMENT OUTCOME;

EID: 80052823864     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2010.01218.x     Document Type: Article

References (21)

1. International Diabetes Federation. (2003) Diabetes atlas second edition executive summary. Brussels: International Diabetes Federation. Available at: (accessed 16 July 2010).
2. American Diabetes Association. (2009) Standards of medical care in diabetes2009. Diabetes Care, 32, S13-61.
3. Renders CM, Valk GD, Griffin SJ, Wagner EH, Eijk Van JT, Assendelft WJ, (2001) Interventions to improve the management of diabetes in primary care, outpatient, and community settings: a systematic review. Diabetes Care, 24, 1821-1833. (Pubitemid 33716489)
4. Hepler CD, Strand LM, (1990) Opportunities and responsibilities in pharmaceutical care. American Journal of Hospital Pharmacy, 47, 533-543. (Pubitemid 20138134)
5. Hepler CD, (2004) Clinical pharmacy, pharmaceutical care, and the quality of drug therapy. Pharmacotherapy, 24, 1491-1498. (Pubitemid 39426343)
6. Machado M, Bajcar J, Guzzo GC, Einarson TR, (2007) Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management. Annals of Pharmacotherapy, 41, 1569-1582. (Pubitemid 47479786)
7. Wermeille J, Bennie M, Brown I, McKnight J, (2004) Pharmaceutical care model for patients with type 2 diabetes: integration of the community pharmacist into the diabetes team-a pilot study. Pharmacy World and Science, 26, 18-25. (Pubitemid 38250176)
8. Sarkadi A, Rosenqvist U, (2004) Experience-based group education in Type 2 diabetes: a randomised controlled trial. Patient Education and Counseling, 53, 291-298. (Pubitemid 38759154)
9. Moher D, Schulz KF, Altman DG, (2001) The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet, 357, 1191-1194. (Pubitemid 32378696)
10. Krass I, Armour CL, Mitchell B, et al. (2007) The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia. Diabetic Medicine, 24, 677-683. (Pubitemid 46808869)
11. Mehuys E, De Bolle L, Van Bortel L, et al. (2008) Medication use and disease management of type 2 diabetes in Belgium. Pharmacy World and Science, 30, 51-56. (Pubitemid 350172647)
12. Osterberg L, Blaschke T, (2005) Adherence to medication. New England Journal of Medicine, 353, 487-497. (Pubitemid 41127293)
13. Hess LM, Raebel MA, Conner DA, Malone DC, (2006) Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Annals of Pharmacotherapy, 40, 1280-1288. (Pubitemid 44204957)
14. Fitzgerald JT, Funnell MM, Hess GE, et al. (1998) The reliability and validity of a brief diabetes knowledge test. Diabetes Care, 21, 706-710. (Pubitemid 28487059)
15. Toobert DJ, Hampson SE, Glasgow RE, (2000) The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care, 23, 943-950. (Pubitemid 30480021)
16. (accessed 13 October 2010).
17. UKPDS Group. (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 352, 837-853.
18. UKPDS Group. (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet, 352, 854-865.
19. Stratton IM, Adler AI, Neil HA, et al. (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. British Medical Journal, 321, 405-412. (Pubitemid 30609442)
20. McCarney R, Warner J, Iliffe S, van Haselen R, Griffin M, Fisher P, (2007) The Hawthorne effect: a randomised, controlled trial. BMC Medical Research Methodology, 7, 30.
21. Welschen LM, Bloemendal E, Nijpels G, et al. (2005) Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin. Cochrane Database Systematic Reviews, 2, CD005060.